Autopsy report · NCT03125187

Study With Heparin Sodium in Intravenous Administration

“Delay in the R\&D stage”

The sponsor’s own words in the registry.

Life of this trial

• Registered 3 years 11 months before it started.
• Suspended: paused, and may or may not restart.
• 24 participants planned (an estimate, not an actual count).

Vital statistics

Status

Suspended

Phase

Phase 1

Sponsor

União Química Farmacêutica Nacional S/A

Sponsor type

Industry

Conditions

Heparin

Interventions

Sodium heparin UQ Intravenous drug administration; Sodium heparin FK Intravenous drug administration

Participants

24 (planned, not actual)

Sites

1

Countries

Brazil

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.